Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

As we usher in 2025, it’s the perfect time to prioritize health and wellness. Recently, Registered Dietitian & Nutritionist Kelly Bristow from Bayer, one of the country's largest life-sciences ...

Bayer's booth presents regenerative agriculture products during the seventh China International Import Expo in Shanghai in November. TANG YANJUN/CHINA NEWS SERVICE Bayer Crop Science, one of the ...

The simple aspirin and drugs used to lower blood pressure can be used to prevent heart disease at a fraction of the cost of traditional cholesterol-busting treatments, researchers claimed today.

Click here to check it out. The mournful “Pardon My Heart” was first heard live on May 16, 1974, when Young played a surprise late-night set at New York’s Bottom Line after a Ry Cooder show.

BAY-3018250 is under clinical development by Bayer and currently in Phase II for Acute Ischemic Stroke. According to GlobalData, Phase II drugs for Acute Ischemic Stroke have a 47% phase transition ...

Physician-scientists found that a subset of artificial heart patients can regenerate heart muscle, which may open the door to new ways to treat and perhaps someday cure heart failure. A research ...

Hamlin worked with Sen. Chuck Schumer (D-N.Y.) on the bill, and the NFL's Smart Hearts Coalition also supported their aim to help improve heart health education around the country. "It's super ...

Elinzanetant is under clinical development by Bayer and currently in Pre-Registration for Vasomotor Symptoms of Menopause (Hot Flashes). According to GlobalData, Pre-Registration drugs for Vasomotor ...

Bill Anderson has shaken up Bayer employees’ day-to-day since taking charge in 2023. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site ...